Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsApproach to therapy of diffuse large B-cell lymphoma in the elderly: the International Society of Geriatric Oncology (SIOG) expert position commentaryRituximab and new regimens for indolent lymphoma: a brief update from 2012 ASCO Annual MeetingRituximab, bendamustine, and lenalidomide in patients with aggressive B cell lymphoma not eligible for high-dose chemotherapy or anthracycline-based therapy: phase I results of the SAKK 38/08 trial.Rituximab, Ara-C, dexamethasone and oxaliplatin (R-ADOx) is effective for treatment of elderly patients with relapsed mantle cell lymphoma.Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.Phase II study of bortezomib in combination with rituximab, cyclophosphamide and prednisone with or without doxorubicin followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma.Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma.Post-transplant bendamustine reduces GvHD while preserving GvL in experimental haploidentical bone marrow transplantation.Bendamustine: role and evidence in lymphoma therapy, an overview.Accelerated therapeutic progress in diffuse large B cell lymphoma.Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings.Rituximab, bendamustine and lenalidomide in patients with aggressive B-cell lymphoma not eligible for anthracycline-based therapy or intensive salvage chemotherapy - SAKK 38/08.Novel therapies for aggressive B-cell lymphomaPixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma.Association of Soluble Interleukin-2 Receptor and C-Reactive Protein with the Efficacy of Bendamustine Salvage Treatment for Indolent Lymphomas and Mantle Cell Lymphoma.Safety and efficacy of rituximab plus bendamustine in relapsed or refractory diffuse large B-cell lymphoma patients: an Italian retrospective multicenter study.Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.
P2860
Q28075606-0E636D74-7664-49B8-93F6-78CFC7086A0BQ28088365-91375E07-4643-4B8A-9B82-058D6C050EDCQ28390181-AC5CD131-E488-4070-B4F6-0804EECF74AAQ33407102-A9A83D1E-14BF-4D2E-837B-03C6B0BD695BQ33409261-8533025A-7D16-4582-9D82-6A407346B2E3Q33409872-6F848544-E91D-4478-8C0A-AAB15574619AQ33416533-B6B47A95-EAD5-4A2A-B1E8-B3A4285FAE3DQ33421147-554457AA-2C2A-4FC7-9FAA-80042E01F62AQ37029856-DFD199C4-5E57-45F2-A900-12FAF6B83974Q38158084-8E905BF0-CD49-4992-9D86-BD41028D1036Q38174498-B8E15CF3-B9E7-427D-864C-AA760AA98F2AQ40494935-C9760AED-0FB6-45ED-9251-F8848DED535AQ40831512-E10D86C9-AA20-45EA-A49E-631681A9069EQ42011578-5DE482E6-92BC-41CF-B18D-DD1004F26AAEQ43412243-CF86A4D3-8E63-425F-BF63-FAA8AFA7FE2DQ47232472-B1DFD20F-294E-410B-94E9-137D17CB9DC9Q52895479-9A797DFB-EC5D-469B-AFF5-239D9611A570Q52969991-BB808720-38AE-4BBF-8F0E-83048316AB4C
P2860
Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Bendamustine with or without r ...... ian Lymphoma Foundation (FIL).
@en
Bendamustine with or without r ...... he Italian Lymphoma Foundation
@nl
type
label
Bendamustine with or without r ...... ian Lymphoma Foundation (FIL).
@en
Bendamustine with or without r ...... he Italian Lymphoma Foundation
@nl
prefLabel
Bendamustine with or without r ...... ian Lymphoma Foundation (FIL).
@en
Bendamustine with or without r ...... he Italian Lymphoma Foundation
@nl
P2093
P2860
P50
P1433
P1476
Bendamustine with or without r ...... lian Lymphoma Foundation (FIL)
@en
P2093
Alfonso D'Arco
Andrea Carpaneto
Anna Marina Liberati
Benedetta Puccini
Caterina Patti
Delia Rota-Scalabrini
Emilio Iannitto
Enrico Orciuolo
Gianluca Gaidano
Luigi Rigacci
P2860
P304
P356
10.1007/S00277-012-1422-5
P577
2012-02-15T00:00:00Z